1. Prevalence of interferon type I signature in CD14 monocytes of patients with Sjögren's syndrome and association with disease activity and BAFF gene expression
- Author
-
Virgil A. S. H. Dalm, Manon E Wildenberg, Zana Brkic, Marjan A. Versnel, Paul L A van Daele, Hemmo A. Drexhage, Cornelia G van Helden-Meeuwsen, Joop P. van de Merwe, Naomi I Maria, Wouter Beumer, Immunology, Internal Medicine, AII - Amsterdam institute for Infection and Immunity, AGEM - Amsterdam Gastroenterology Endocrinology Metabolism, and Gastroenterology and Hepatology
- Subjects
Adult ,Male ,CD14 ,Lymphocyte ,Immunology ,Lipopolysaccharide Receptors ,Gene Expression ,Real-Time Polymerase Chain Reaction ,Monocytes ,General Biochemistry, Genetics and Molecular Biology ,stomatognathic system ,Rheumatology ,Interferon ,B-Cell Activating Factor ,Prevalence ,medicine ,Humans ,Immunology and Allergy ,Rheumatoid factor ,RNA, Messenger ,B-cell activating factor ,Aged ,business.industry ,Monocyte ,Autoantibody ,Middle Aged ,Clinical and Epidemiological Research ,Up-Regulation ,stomatognathic diseases ,Sjogren's Syndrome ,medicine.anatomical_structure ,Interferon Type I ,Female ,business ,Biomarkers ,Interferon type I ,medicine.drug - Abstract
Objective To determine the prevalence of upregulation of interferon (IFN) type I inducible genes, the so called ‘IFN type I signature’, in CD14 monocytes in 69 patients with primary Sjögren's syndrome (pSS) and 44 healthy controls (HC) and correlate it with disease manifestations and expression of B cell activating factor (BAFF). Methods Expression of IFI44L, IFI44, IFIT3, LY6E and MX1 was measured using real time quantitative PCR in monocytes. Expression values were used to calculate IFN type I scores for each subject. pSS patients positive for the IFN type I signature (IFN score≥10) and patients negative for the signature (IFN score
- Published
- 2012